Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
Open accessThe DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.
Abstract
Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to their capacity for local engrafting and differentiating into multiple tissue types. However, recent studies have revealed that implanted cells do not survive for long, and that the benefits of MSC therapy could be due to the vast array of bioactive factors they produce, which play an important role in the regulation of key biologic processes. Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product. Nevertheless, regulatory requirements for manufacturing and quality control will be necessary to establish the safety and efficacy profile of these products. Among MSCs, human uterine cervical stem cells (hUCESCs) may be a good candidate for obtaining secretome-derived products. hUCESCs are obtained by Pap cervical smear, which is a less invasive and painful method than those used for obtaining other MSCs (for example, from bone marrow or adipose tissue). Moreover, due to easy isolation and a high proliferative rate, it is possible to obtain large amounts of hUCESCs or secretome-derived products for research and clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 1×
“The Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy established in 2006 the minimal identifying characteristics for human MSCs [29]: (a) plastic-adherent cells when maintained in standard culture conditions; (b) expression of CD105, CD73 and CD90, and lack expression of CD4…”
BackgroundValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo
Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., & Shi, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240309797 · Cited by 4,570 · cited 1×
“They have also been isolated from other adult tissues such as adipose tissue [10], skin [11], lung [12], synovial membrane [13], dental pulp [14], nasal olfactory mucosa [15], breast milk [16], scalp tissue [17], muscle [18], periosteum [19], corneal limbus [20], peripheral blood [21], endometrial and menstrual blood…”
BackgroundA perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991 · cited 1×
“All of these MCSs can be isolated and expanded from stroma of many tissues, the bone marrow and subcutaneous fat being the preferred sources [28].”
BackgroundDi Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226 · cited 1×
“found that MSCs inhibit proliferation of CD4+ and CD8+ T cells [78].”
BackgroundMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734 · cited 1×
“The most promising potential applications involve the treatment of graft versus host disease [74,75], as well as of autoimmune and inflammatory diseases, such as insulin systemic lupus erythematosus (SLE), diabetes mellitus type I, (SLE), multiple sclerosis or Crohn’s”
BackgroundFriedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“[9], who described a fibroblast-like population able to secrete growth factors and cytokines relevant for hematopoiesis and others processes.”
BackgroundNémeth, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302 · cited 1×
“This is relevant because CAFs, a prevailing component of tumor stroma, contribute to tumor growth, invasion and dissemination [145,146].”
Background
Research works printed but not linked: 1
- 95. Litwack G. Human Biochemistry and Disease. Academic Press; Cambridge, MA, USA: 2008.
Cited by
Items 301–400 of 1,000
Naem, M. A., Bourebaba, L., Kucharczyk, K., Röcken, M., & Marycz, K. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09932-0 · Cited by 43
“Although the autologous and / or allogeneic transplantation of stem cells of various origins has been the basis of regenerative medicine for many years, the emergence of a new type of biological regulation involving the communication between cells via their secreted substances, more commonly known as secretome, is act…”
BackgroundApplication of dental pulp stem cells for bone regeneration
Liu, Y., Xiong, W., Li, J., Feng, H., Jing, S., Liu, Y., Zhou, H., Duan, L., Fu, D., Xu, C., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1339573 · Cited by 46
Mesenchymal Stem Cell Secretome: Cell-free Therapeutic Strategy in Regenerative Medicine
Meiliana, A., Dewi, N. M., & Wijaya, A. (2019) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v11i2.839 · Cited by 42
“thus off-the-shelf secretome therapies could be immediately available for treatment of urgent conditions such as cerebral ischemia, myocardial infarction, or military trauma; and the biological product is available for modification adjust to desired therapeutic cell-specific effects.(23) By preventing cell apoptosis,…”
BackgroundNilforoushzadeh, M. A., Aghdami, N., & Taghiabadi, E. (2020) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-020-00266-4 · Cited by 36
Huang, Y., Ma, Z., Kuang, X., Zhang, Q., Li, H., & Lai, D. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02280-2 · Cited by 35
Priming human adipose‐derived mesenchymal stem cells for corneal surface regeneration
Nieto‐Nicolau, N., Martinez-Conesa, E. M., Fuentes‐Julián, S., Arnalich‐Montiel, F., García‐Tuñón, I., Miguel, M. P. D., & Casaroli-Marano, R. P. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16501 · Cited by 39
“AT- MSC exert a paracrine action that benefit the regenerative processes through trophic factors secretion [15,17] suppressing, the inflammation and immune reaction signalling [18].”
BackgroundManjua, A. C., Cabral, J. M. S., Portugal, C. A. M., & Ferreira, F. C. (2021) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2021.1927834 · Cited by 39
Anti-inflammatory effect of dental pulp stem cells
Li, F., Wang, X., Shi, J., Wu, S., Xing, W., & He, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1284868 · Cited by 47
“Conditioned media from various stem cell types have been shown to have considerable potential in the treatment of a variety of refractory diseases (127).”
BackgroundPhysoxia alters human mesenchymal stem cell secretome
Merkhan, M. M., Shephard, M. T., & Forsyth, N. R. (2021) · Journal of Tissue Engineering · doi:10.1177/20417314211056132 · Cited by 39
Cell Secretome Strategies for Controlled Drug Delivery and Wound-Healing Applications
Ibrahim, R., Mndlovu, H., Kumar, P., Adeyemi, S. A., & Choonara, Y. E. (2022) · Polymers · doi:10.3390/polym14142929 · Cited by 44
“The reduction of cell culture and immediate secretome therapies can be applied to manage acute pathological conditions such as military trauma, cerebral ischemia, and myocardial infarction, and modification of the biological product can take place to achieve a cell-specific effect [19,50].”
BackgroundLiu, F., Sun, T., An, Y., Ming, L., Li, Y., Zhou, Z., & Shang, F. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1050916 · Cited by 38
“Various studies have demonstrated that EVs enhance angiogenesis near tendon-bone junctions in vivo (Vizoso et al., 2017), which is shown by promoting the expression of angiogenic factors and tube formation and stimulating the proliferation and migration of endothelial cells (Zhang B.”
BackgroundMunda, M., & Velnar, T. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.9518 · Cited by 36
Exosomes in nanomedicine: a promising cell-free therapeutic intervention in burn wounds
Manzoor, T., Farooq, N., Sharma, A., Shiekh, P. A., Hassan, A., Dar, L. A., Nazir, J., Godha, M., Sheikh, F. A., Gugjoo, M. B., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03970-3 · Cited by 38
“…stance, releasing EVs that effectively suppress and restrain inflammation by inhibiting M1 macrophages, dendritic cell antigen presentation, natural killer cells, and various T cell subsets that contribute to inflammatory responses (i.e., Th1, Th17, and cytotoxic T cells) [24, 33, 34].”
BackgroundTrabecular Meshwork Regeneration—a Potential Treatment for Glaucoma
Castro, A. D., & Du, Y. (2019) · Current Ophthalmology Reports · doi:10.1007/s40135-019-00203-2 · Cited by 35
Gonzalez‐Pujana, A., Igartua, M., Santos‐Vizcaíno, E., & Hernández, R. M. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1714587 · Cited by 36
“their therapeutic activity [15,38] (Figure 1(c)).”
Mesenchymal Stem Cells: The Past Present and Future
Attia, N., & Mashal, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_595 · Cited by 36
Sarvar, D. P., Effatpanah, H., Akbarzadehlaleh, P., & Shamsasenjan, K. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02875-3 · Cited by 36
Gene and Cell Therapy for Epilepsy: A Mini Review
Shaimardanova, A. A., Chulpanova, D. S., Mullagulova, A. I., Afawi, Z., Gamirova, R., Solovyeva, V. V., & Rizvanov, A. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.868531 · Cited by 34
Jenner, F., Wagner, A., Ribitsch, I., Ludewig, E., Trujanovic, R., Rohde, E., von Rechenberg, B., Gimona, M., & Traweger, A. (2023) · The American Journal of Sports Medicine · doi:10.1177/03635465221145958 · Cited by 38
“The application of sEVs instead of live, replicating cells offers several therapeutic advantages, including reduced safety concerns, easier production, standardization and storage, greater homogeneity, and the potential for off-the-shelf treatments using allogeneic donor cells.(8,19,22,23,34,48,50) The current pilot s…”
BackgroundCell Encapsulation and 3D Bioprinting for Therapeutic Cell Transplantation
Samadi, A., Moammeri, A., Pourmadadi, M., Abbasi, P., Hosseinpour, Z., Farokh, A., Shamsabadipour, A., Heydari, M., & Mohammadi, M. R. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c01183 · Cited by 38
Prado-Yupanqui, J. W., Ramírez-Orrego, L., Cortez, D., Vera-Ponce, V. J., Chenet, S. M., Tejedo, J. R., & Tapia‐Limonchi, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051926 · Cited by 46
“Subsequently, the modified proteins are transferred to the Golgi complex for final processing and released into the extracellular environment via exocytosis [9,10].”
Tian, J., Popal, M. S., Zhao, Y., Liu, Y., Chen, K., & Liu, Y. (2018) · Aging and Disease · doi:10.14336/ad.2018.1020 · Cited by 35
Pokrovskaya, L. A., Zubareva, E. V., Nadezhdin, S. V., Lysenko, A. S., & Litovkina, T. L. (2020) · Research Results in Pharmacology · doi:10.3897/rrpharmacology.6.49413 · Cited by 39
“And a conditioned medium from MSCs treated with TFG-α induces blood vessel growth in an in vivo assay (De Luca et al. 2011; Vizoso et al. 2017).”
BackgroundInfluentialJabbehdari, S., Yazdanpanah, G., Kanu, L. N., Chen, E., Kang, K. B., Anwar, K. N., Ghassemi, M., Hematti, P., Rosenblatt, M. I., & Djalilian, A. R. (2020) · Current Eye Research · doi:10.1080/02713683.2020.1762227 · Cited by 36
Sabzevari, R., Roushandeh, A. M., Mehdipour, A., Alini, M., & Roudkenar, M. H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118381 · Cited by 36
TEDESCO, M., Bellei, B., Garelli, V., Caputo, S., Latini, A., Giuliani, M., Cota, C., Chichierchia, G., Romani, C., Foddai, M. L., et al. (2020) · Dermatologic Therapy · doi:10.1111/dth.14277 · Cited by 35
“Age median (range) 53 (18-78) 59 (29-78) 49 (18-76)”
Eiró, N., Fraile, M., Fernández-Francos, S., Sánchez, R., Costa, L. A., & Vizoso, F. J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00620-6 · Cited by 36
Self-citationAdipose-derived stem cell secretome as a cell-free product for cutaneous wound healing
Ajit, A., & Gopalankutty, I. A. (2021) · 3 Biotech · doi:10.1007/s13205-021-02958-7 · Cited by 35
Saleem, R., Mohamed‐Ahmed, S., Elnour, R., Berggreen, E., Mustafa, K. B. E., & Al‐Sharabi, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413458 · Cited by 34
“However, current evidence indicates that ROS in the inflamed bone tissue may lead to impaired cell metabolism and decreased cell viability of engrafted MSC, which consequently limits their therapeutic effects and delays osteogenesis [9,10].”
BackgroundWang, M., Zhao, J., Li, J., Meng, M., & Zhu, M. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03749-6 · Cited by 36
“ADSC-CM and ADSC-Exo have recently gained attention as alternatives to conventional ADSC therapy [91].”
BackgroundMansoori, M., Solhjoo, S., Palmerini, M. G., Nematollahi‐Mahani, S. N., & Ezzatabadipour, M. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01484-3 · Cited by 37
Jabbehdari, S., Yazdanpanah, G., Kanu, L. N., Anwar, K. N., Shen, X., Rabiee, B., Putra, I., Eslani, M., Rosenblatt, M. I., Hematti, P., et al. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.3.26 · Cited by 32
Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution
Samarelli, A. V., Tonelli, R., Heijink, I. H., Medina, A. M., Marchioni, A., Bruzzi, G., Castaniere, I., Andrisani, D., Gozzi, F., Manicardi, L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.692551 · Cited by 36
“This includes a growing literature in which MSCsderived EVs can be as effective as the MSCs themselves in preclinical models of lung injuries (Cruz and Patricia, 2020; Harrell et al., 2019; Beer et al., 2017; Vizoso et al., 2017).”
BackgroundMapping the Secretome of Dental Pulp Stem Cells Under Variable Microenvironmental Conditions
Bousnaki, M., Bakopoulou, A., Pich, A., Papachristou, E., Κritis, A., & Koidis, P. T. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10255-2 · Cited by 38
“injury/ischemia/stroke, among several others with high prevalence and/or incidence [43].”
BackgroundShan, C., Yan, L., Wang, K., & Li, P. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.88500 · Cited by 35
“On the flip side, MSCs act as a framework for the growth of tumor cell and control their growth through the secretion of various substances, including cytokines, chemokines, and growth factors[6].”
BackgroundSendón-Lago, J., Seoane, S., Martínez-Ordóñez, A., Eiró, N., Saá, J., Vizoso, F. J., González, F., Pérez-Fernández, R., & Bermúdez, M. A. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.12.004 · Cited by 32
Self-citationLuo, Y., Wang, B., Liu, J., Ma, F., Luo, D., Zheng, Z., Lu, Q., Zhou, W., Zheng, Y., Zhang, C., et al. (2020) · Aging · doi:10.18632/aging.202241 · Cited by 33
“MSCderived conditioned medium (MSC-CM) containing numerous trophic factors represents an alternative to MSC transplantation [10].”
BackgroundCAR T-cells profiling in carcinogenesis and tumorigenesis: An overview of CAR T-cells cancer therapy
Samadani, A. A., Keymoradzdeh, A., Shams, S., Soleymanpour, A., Rashidy‐Pour, A., Hashemian, H., Vahidi, S., & Norollahi, S. E. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107201 · Cited by 33
Gallo, A., Cuscino, N., Contino, F., Bulati, M., Pampalone, M., Amico, G., Zito, G., Carcione, C., Centi, C., Bertani, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020863 · Cited by 33
Extracellular vesicle-mediated cellular crosstalk in lung repair, remodelling and regeneration
Kadota, T., Fujita, Y., Araya, J., Ochiya, T., & Kuwano, K. (2022) · European Respiratory Review · doi:10.1183/16000617.0106-2021 · Cited by 39
Wang, B., Pang, M., Song, Y., Wang, H., Pan, Q., Bai, S., Lei, X., Wei, S., Zong, Z., Lin, S., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10354 · Cited by 35
“effects of MSCs are mainly attributed to their paracrine factors in vivo.(7) The function of the secretome is differed and depends on the origin of the cell.”
BackgroundArango-Rodríguez, M. L., Mateus, L. C., Sossa, C., Becerra‐Bayona, S. M., Solarte-David, V. A., Ochoa, M., Viviescas, L. T. G., Berrio, A. M. V., Serrano, S. E., Vargas, O., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03427-z · Cited by 31
Stem cell exosomes: new hope and future potential for relieving liver fibrosis
Li, L., Liu, Y., Wang, K., Mo, J., Weng, Z., Jiang, H., & Jin, C. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0854 · Cited by 36
Silva, K. D., Kumar, P., & Choonara, Y. E. (2025) · Wound Repair and Regeneration · doi:10.1111/wrr.13251 · Cited by 34
“17,21,37,68 This review will consider how the secretome can provide clinically relevant pharmaceutical targets and act as clinical novel therapies.”
Exosomes in neurodegenerative diseases: Therapeutic potential and modification methods
Chen, H., Li, N., Cai, Y., Ma, C., Ye, Y., Shi, X., Guo, J., Han, Z., Liu, Y., & Wei, X. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00720 · Cited by 33
“Consequently, stem cell-derived exosomes show significant potential for therapeutic applications in tissue regeneration (Vizoso et al., 2017).”
Mesenchymal Stem Cell-Based Therapies: Challenges and Enhancement Strategies
Wong, R. S.-Y., Tan, E. W., & Goh, B. H. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01895-z · Cited by 33
“…to the total set of factors secreted by MSCs, which include bioactive factors like cytokines, growth factors, hormones, chemokines, cell adhesion molecules, microRNAs (miRNAs), long-coding RNAs (lncRNAs), as well as the extracellular vesicles consisting of microvesicles and exosomes [ 77, 78].”
Shaping the Future of Perinatal Cells: Lessons From the Past and Interpretations of the Present
Silini, A. R., Masserdotti, A., Papait, A., & Parolini, O. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00075 · Cited by 33
“…such as resolving several safety concerns potentially associated with the transplantation of live and proliferative cells, it allows for storage without the use of potentially toxic cryopreservation agents and for easier production of a sufficient quantity of product (Vizoso et al., 2017).”
Gonçalves, F. D. C., Korevaar, S. S., Ortiz‐Virumbrales, M., Baan, C. C., Reinders, M. E. J., Merino, A. M., Lombardo, E., & Hoogduijn, M. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.651109 · Cited by 32
Potential of different cells-derived exosomal microRNA cargos for treating spinal cord injury
Pan, D., Liu, W., Zhu, S., Fan, B., Yu, N., Ning, G., & Feng, S. (2021) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2021.09.008 · Cited by 33
Nilforoushzadeh, M. A., Aghdami, N., & Taghiabadi, E. (2021) · PubMed Central · doi:10.22074/cellj.2021.7352 · Cited by 42
A Comparative Study of Canine Mesenchymal Stem Cells Isolated from Different Sources
Humeník, F., Maloveská, M., Hudáková, N., Petroušková, P., Horňáková, Ľ., Domaniža, M., Mudroňová, D., Bodnárová, S., & Cizkova, D. (2022) · Animals · doi:10.3390/ani12121502 · Cited by 30
“A better understanding of the factors of the biological function that makes up the secretome in relation to its tissue source will allow for the development of more effective and diseases targeted therapy [18].”
BackgroundThe Pivotal Role of Stem Cells in Veterinary Regenerative Medicine and Tissue Engineering
El‐Husseiny, H. M., Mady, E. A., Helal, M., & Tanaka, R. (2022) · Veterinary Sciences · doi:10.3390/vetsci9110648 · Cited by 39
“Thus, it presents an outstanding immunomodulatory ability [70].”
BackgroundRagni, E., Luca, P. D., Orfei, C. P., Colombini, A., Viganò, M., Lugano, G., Bollati, V., & de Girolamo, L. (2019) · Cells · doi:10.3390/cells8040369 · Cited by 31
“MSCs may be easily isolated from almost all stromal tissues, have potential for ex vivo expansion and the ability to secrete a range of trophic factors, either free (cytokines or chemokines) or conveyed within extracellular vesicles (EVs) (proteins, lipids and nucleic acids as miRNAs) [3].”
Avnet, S., Lemma, S., Cortini, M., Di Pompo, G., Perut, F., & Baldini, N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00305 · Cited by 29
The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges
Cortes‐Dericks, L., & Galetta, D. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00459-7 · Cited by 30
Proteomic and Ultrastructural Analysis of Cellulite—New Findings on an Old Topic
Conti, G., Zingaretti, N., Amuso, D., Prè, E. D., Brandi, J., Cecconi, D., Manfredi, M., Marengo, E., Boschi, F., Riccio, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062077 · Cited by 29
“Exosomes are lipid vesicles secreted by adipocytes, or by adipose mesenchymal stem cells, with the aim to release molecular mediators, in particular in stress conditions [23], and are considered a critical messenger for cell-cell communication.”
BackgroundZhang, Z., Li, Y., Zhang, T., Shi, M., Song, X. G., Yang, S., Liu, H., Zhang, M., Cui, Q., & Li, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.654084 · Cited by 31
Calcium channels and their role in regenerative medicine
Ahamad, N., & Singh, B. B. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i4.260 · Cited by 31
Basic and Preclinical Research for Personalized Medicine
Lattanzi, W., Ripoli, C., Greco, V., Barba, M., Iavarone, F., Minucci, A., Urbani, A., Grassi, C., & Parolini, O. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050354 · Cited by 32
“This MSC secretome has considerable advantages over cell-based strategies for manufacturing, safety, handling, storage, shelf life, hence potential translation into cell-free biological therapies [33].”
BackgroundOrmazábal, V., Nova‐Lamperti, E., Rojas, D., Zuñiga, F. A., Escudero, C., Lagos, P., Moreno, A., Pavez, Y., Reyes, C., Yáñez, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020941 · Cited by 34
“cell availability influenced by the comorbidities [38] and low cell survival rates after implantation [39].”
BackgroundUsategui‐Martín, R., Puertas‐Neyra, K., Galindo‐Cabello, N., Hernández‐Rodríguez, L., González‐Pérez, F., Rodríguez‐Cabello, J. C., González‐Sarmiento, R., Jimeno, J. C. P., & Fernandez‐Bueno, I. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.4.27 · Cited by 32
Tilotta, V., Vadalà, G., Ambrosio, L., Cicione, C., Giacomo, G. D., Russo, F., Papalia, R., & Denaro, V. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1152207 · Cited by 35
“It is well known that the efficacy of MSCs is mainly mediated by secreted bioactive factors exerting anabolic, proliferative and immunomodulating effect on target cells via paracrine mechanisms (Vizoso et al., 2017).”
BackgroundLiu, L., Zhou, Y., Zhao, X., Yang, X., Wan, X., An, Z., Zhang, H., Tian, J., Ge, C.-J., & Song, X. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2809203 · Cited by 29
Abdrabou, A., Youssef, A. M., El‐Khonezy, M. I., Kotob, S. E., & Kishta, M. S. (2025) · ChemistryOpen · doi:10.1002/open.202500261 · Cited by 29
Malara, N., Gentile, F., Coppedé, N., Coluccio, M. L., Candeloro, P., Perozziello, G., Ferrara, L., Giannetto, M., Careri, M., Castellini, A., et al. (2018) · npj Precision Oncology · doi:10.1038/s41698-018-0069-7 · Cited by 30
Emukah, C., Dittmar, E., Naqvi, R., Martinez, J., Corral, A., Moreira, A., & Moreira, A. G. (2019) · Respiratory Research · doi:10.1186/s12931-019-1212-x · Cited by 30
Skiles, M. L., Marzan, A., Brown, K., & Shamonki, J. M. (2020) · Cytotherapy · doi:10.1016/j.jcyt.2020.06.002 · Cited by 29
Advances in Stem Cell-Based Therapy for Hair Loss.
Egger, A. N., Tomic‐Canic, M., & Tosti, A. (2020) · PubMed · doi:10.32113/cellr4_20209_2894 · Cited by 29
Kato, M., Tsunekawa, S., Nakamura, N., Miura‐Yura, E., Yamada, Y., Hayashi, Y., Nakai‐Shimoda, H., Asano, S., Hayami, T., Motegi, M., et al. (2020) · Cells · doi:10.3390/cells9112385 · Cited by 30
Novel therapies using cell sheets engineered from allogeneic mesenchymal stem/stromal cells
Kondō, M., Kameishi, S., Grainger, D. W., & Okano, T. (2020) · Emerging Topics in Life Sciences · doi:10.1042/etls20200151 · Cited by 31
Riaud, M., Martínez, M. C., & Montero‐Menei, C. N. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121195 · Cited by 30
Silini, A. R., Papait, A., Cargnoni, A., Vertua, E., Romele, P., Signoroni, P. B., Magatti, M., Munari, S. D., Masserdotti, A., Pasotti, A., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02607-z · Cited by 28
Ramalingam, M., Jeong, H., Hwang, J., Cho, H., Kim, B. C., Kim, E., & Jang, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084193 · Cited by 28
“Their secretome or conditioned medium constitutes a complex mixture of soluble products, including lipids, proteins, nucleic acids, chemokines, cytokines, growth factors, hormones, microvesicles, and exosomes [38,39], which are believed to be modulators of several biological processes and could thus provide promising…”
BackgroundLi, Q., Qi, G., Lutter, D., Beard, W. L., Souza, C. R. S., Highland, M. A., Wu, W., Li, P., Zhang, Y., Atala, A., et al. (2022) · Biomolecules · doi:10.3390/biom12091317 · Cited by 32
“In addition to cell properties, factors secreted by hADMSCs have been shown to play important roles in their therapeutic potentials [56,57].”
BackgroundEmerging Roles of Mesenchymal Stem/Stromal-Cell-Derived Extracellular Vesicles in Cancer Therapy
Nicodemou, A., Bernatova, S., Čeháková, M., & Danišovič, Ľ. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051453 · Cited by 31
“mechanisms, through the secretion of a wide array of growth factors, cytokines, and extracellular vesicles (EVs) that collectively contribute to enhancing tissue repair and mitigating inflammatory and immune responses [5,6].”
BackgroundMyths, reality and future of mesenchymal stem cell therapy
Полтавцева, Р. А., Poltavtsev, A. V., Lutsenko, G. V., & Svirshchevskaya, E. V. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2961-4 · Cited by 31
Holkar, K., Vaidya, A., Pethe, P. S., Kale, V. P., & Ingavle, G. C. (2020) · Materialia · doi:10.1016/j.mtla.2020.100736 · Cited by 31
Rogulska, O. Y., Vacková, I., Pražák, Š., Turnovcová, K., Kubinová, Š., Bačáková, L., Jendelová, P., & Petrenko, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-60787-z · Cited by 28
“Compared to classic whole-cell MSC infusions/injections, the use of MSC secretome (MSC-sec) as a cell-derived product has benefits in terms of safety, reproducibility, and the possibility of technically facile and economical mass production 13 .”
MethodSampath, S. J. P., Rath, S. N., Kotikalapudi, N., & Venkatesan, V. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00874-z · Cited by 27
Contentin, R., Jammes, M., Bourdon, B., Cassé, F., Bianchi, A., Audigié, F., Branly, T., Velot, É., & Galéra, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105795 · Cited by 30
“Indeed, the MSC secretome decreased the expression of pro-apoptotic molecules by cardiomyocytes in a model of myocardial infarction in rats [22].”
BackgroundSun, H. R., Zhang, T., & Gao, J. (2022) · BioDrugs · doi:10.1007/s40259-022-00555-5 · Cited by 28
Trends in using mesenchymal stromal/stem cells (MSCs) in treating corneal diseases
Venkatakrishnan, J., Saeed, Y., & Kao, W. W. ‐. (2022) · The Ocular Surface · doi:10.1016/j.jtos.2022.10.003 · Cited by 29
Li, W., & Yu, L. (2024) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2024.2360008 · Cited by 30
“Without the drawbacks of cell therapy, they exhibit good bio-compatibility, low toxicity, stability in biological fluids, and convenient manufacturing, storage, and delivery [10, 14, 15].”
InfluentialMagne, B., Lataillade, J., & Trouillas, M. (2018) · Stem Cells and Development · doi:10.1089/scd.2018.0094 · Cited by 31
“Due to the fact that MSCs mainly operate through their paracrine secretions, derivative secretory products, such as conditioned media or microvesicles, have drawn much attention in the recent years [114].”
Polypyrrole increases branching and neurite extension by Neuro2A cells on PBAT ultrathin fibers
Granato, A. E. C., Ribeiro, A. C., Marciano, F. R., Rodrigues, B. V. M., Lobo, A. O., & Porcionatto, M. A. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.05.004 · Cited by 27
Mizukami, A., Thomé, C. H., Ferreira, G. A., Lanfredi, G. P., Covas, D. T., Pitteri, S. J., Swiech, K., & Faça, V. M. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00154 · Cited by 28
“Indeed, studies have shown that <1% of MSC survive for more than 1 week after infusion (Vizoso et al., 2017).”
BackgroundExosomes as promising bioactive materials in the treatment of spinal cord injury
Li, Y., Luo, W., Meng, C., Shi, K., Gu, R., & Cui, S. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03952-5 · Cited by 29
Chen, Z., Pang, Q.-M., Zhan, J., Liu, J., Zhao, W., Dong, L., & Huang, W. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101340 · Cited by 39
“In recent years, more studies have found that the primary mechanism by which MSCs exert their functions is not through direct differentiation and tissue replacement but through paracrine pathways [15,16].”
Chandra, P. K., Gerlach, S. L., Wu, C., Khurana, N., Swientoniewski, L. T., Abdel‐Mageed, A. B., Li, J. J., Braun, S. E., & Mondal, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-32657-y · Cited by 27
The interplay between adipose-derived stem cells and bladder cancer cells
Maj, M., Kokocha, A., Bajek, A., & Drewa, T. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-33397-9 · Cited by 29
Metabolomics Analysis of Mesenchymal Stem Cells.
Goodarzi, P., Alavi-Moghadam, S., Payab, M., Larijani, B. A., Rahim, F., Gilany, K., Bana, N., Tayanloo-Beik, A., Heravani, N. F., Hadavandkhani, M., et al. (2019) · PubMed Central · doi:10.22088/ijmcm.bums.8.2.30 · Cited by 30
“Metabolomics can support quantification of MSC-CM metabolites by different targeted and non-targeted methods (91).”
BackgroundMethodLai, R., Cai, C., Wu, W., Hu, P., & Wang, Q. (2020) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3089 · Cited by 29
“More importantly, the stimulation or modification of these stem cells with traditional methods significantly increases the risk of developing cancer (Hu et al., 2019; Jafari et al., 2019; Vizoso et al., 2017).”
BackgroundPotency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19
Chouw, A., Milanda, T., Sartika, C. R., Kirana, M. N., Halim, D., & Faried, A. (2021) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-021-00202-5 · Cited by 29
The Lack of a Representative Tendinopathy Model Hampers Fundamental Mesenchymal Stem Cell Research
Meeremans, M., de Walle, G. R. V., Vlierberghe, S. V., & Schauwer, C. D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.651164 · Cited by 27
A “cell-free treatment” for tendon injuries: adipose stem cell-derived exosomes
Lyu, K., Liu, T., Chen, Y., Lu, J., Jiang, L., Liu, X., Liu, X., Li, Y., & Li, S. (2022) · European journal of medical research · doi:10.1186/s40001-022-00707-x · Cited by 27
“In terms of non-surgical approaches, currently, cell-free therapy in regenerative medicine ranks among the top treatments for tendon injuries, with the most prominent source being the secretome of stem cell origin [16].”
BackgroundRegenerative Medicine-Based Treatment for Vitiligo: An Overview
Bellei, B., Papaccio, F., & Picardo, M. (2022) · Biomedicines · doi:10.3390/biomedicines10112744 · Cited by 31
Silveira, B. M. D., Ribeiro, T. O., Freitas, R. D. S., Carreira, A. C. O., Gonçalves, M. D. S., Sogayar, M. C., Meyer, R., Birbrair, A., & Fortuna, V. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277863 · Cited by 30
Applications of functionally-adapted hydrogels in tendon repair
Hu, J., Liu, S., & Fan, C. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1135090 · Cited by 35
“Exosomes facilitate intercellular communication via a paracrine pathway and the sustained release of exosomes from hydrogel-based materials may offer a promising strategy for tendon repair (VillarroyaBeltri et al., 2014; Vizoso et al., 2017; Tang et al., 2021).”
BackgroundExtracellular vesicles in osteoarthritis of peripheral joint and temporomandibular joint
Yang, B., Li, X., Fu, C., Cai, W., Meng, B., Qu, Y., Kou, X., & Zhang, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1158744 · Cited by 32
“The therapeutic effects of stem cells are mainly attributed to their paracrine effects, and EVs are one of the important components of paracrine secretion (26).”
BackgroundThe Emerging Role of Mesenchymal Stem Cells in Vascular Calcification
Xie, C., Ouyang, L., Chen, J., Zhang, H., Luo, P., Wang, J., & Huang, H. (2019) · Stem Cells International · doi:10.1155/2019/2875189 · Cited by 29
“It has been reported that less than 1%MSCs survive for more than one week after systemic administration [73, 74], which is a huge challenge in stem cell therapy.”
Background
Metadata
- Authors
- Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R.
- Affiliations
- Fundación Hospital de Jove (ES)
- Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33290 Gijón, Spain
- Department of Obstetrics & Gynecology, C/Ramon y Cajal 7, University of Valladolid, 47005 Valladolid, Spain
- Department of Physiology-Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Santiago de Compostela, Spain
- Corresponding author
- Vizoso, Francisco
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-25
- Volume
- 18
- Issue
- 9
- Pages
- 1852
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5618501
- OpenAlex
- W2746710261
- Cited by
- 1,363
- References
- 235
- Citations by year
- 2026: 142 · 2025: 165 · 2024: 153 · 2023: 182 · 2022: 186 · 2021: 178 · 2020: 158 · 2019: 130 · 2018: 62 · 2017: 6
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Council
- European Regional Development Fund (SAF2015-69221-R)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, cell-free therapy, conditioned medium, exosomes, regenerative medicine, stem cell therapy, quality control, regulatory requirements
- MeSH terms
- Clinical Studies as Topic, Animals, Humans, Stem Cells, Culture Media, Conditioned, Regenerative Medicine, Mesenchymal Stem Cell Transplantation, Cell-Derived Microparticles, Exosomes, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.